Toxicity of platinum compounds

Author： Hartmann Jörg Thomas Lipp Hans-Peter

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.6, 2003-06, pp. : 889-901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymer-platinum compounds

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 661-662

Informa Healthcare

Access to resources Recommend Favorite

Strategies to Improve the Efficacy of Platinum Compounds

Current Medicinal Chemistry, Vol. 16, Iss. 19, 2009-07 ,pp. : 2355-2365

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical studies with new pyrrolidine platinum(II) compounds

By Sampedro F. van Haperen V.R. Izquierdo M. Vicens M. Santalo P. Pueyo M. Llagostera M. Marcuello E. De Andres L.

European Journal of Medicinal Chemistry, Vol. 30, Iss. 6, 1995-01 ,pp. : 497-501

Elsevier

Access to resources Recommend Favorite

Recent developments in antitumour platinum coordination compounds

By Momekov Georgi Momekova Denitsa

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1383-1403

Informa Healthcare

Access to resources Recommend Favorite

Metallothioneins and Platinum(II) Anti-Tumor Compounds

Current Medicinal Chemistry, Vol. 16, Iss. 5, 2009-02 ,pp. : 522-537

Bentham Science Publishers

Access to resources Recommend Favorite